This site is intended for healthcare professionals

account_circleSign in
Go to /sign-in page

You can view 5 more pages before signing in

Dantrolene in the treatment of spasticity

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • dantrolene sodium - inhibits the release of calcium from the sarcoplasmic reticulum and thus causing a dissociation of excitation-contraction coupling. The main side effect is hepatotoxicity

  • evidence from double-blind comparative studies suggest that the efficacy of dantrolene is comparable to that of baclofen and diazepam (1,2)

Reference:

  • (1) Ward A, Chaffman MO, Sorkin EM (1986). Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity. Drugs, 32, 130-68.
  • (2) Schmidt RT, Lee RH, Spehlmann R (1976). Comparison of dantrolene sodium and diazepam in the treatment of spasticity. J Neurosurg Psychiatry, 39, 350-6.

Related pages

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page